Annual Cash & Cash Equivalents
$13.34 M
+$3.91 M+41.49%
December 1, 2023
Summary
- As of February 7, 2025, PTPI annual cash & cash equivalents is $13.34 million, with the most recent change of +$3.91 million (+41.49%) on December 1, 2023.
- During the last 3 years, PTPI annual cash & cash equivalents has fallen by -$3.80 million (-22.19%).
- PTPI annual cash & cash equivalents is now -44.07% below its all-time high of $23.85 million, reached on December 31, 2021.
Performance
PTPI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.89 M
-$3.57 M-47.79%
September 1, 2024
Summary
- As of February 7, 2025, PTPI quarterly cash and cash equivalents is $3.89 million, with the most recent change of -$3.57 million (-47.79%) on September 1, 2024.
- Over the past year, PTPI quarterly cash and cash equivalents has dropped by -$14.08 million (-78.33%).
- PTPI quarterly cash and cash equivalents is now -83.67% below its all-time high of $23.85 million, reached on December 31, 2021.
Performance
PTPI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PTPI Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +41.5% | -78.3% |
3 y3 years | -22.2% | -53.2% |
5 y5 years | +521.5% | -53.2% |
PTPI Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -44.1% | +41.5% | -83.7% | at low |
5 y | 5-year | -44.1% | +521.5% | -83.7% | at low |
alltime | all time | -44.1% | +521.5% | -83.7% | at low |
Petros Pharmaceuticals Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $3.89 M(-47.8%) |
Jun 2024 | - | $7.46 M(-32.7%) |
Mar 2024 | - | $11.08 M(-16.9%) |
Dec 2023 | $13.34 M(+41.5%) | $13.34 M(-25.8%) |
Sep 2023 | - | $17.97 M(+143.3%) |
Jun 2023 | - | $7.38 M(-11.2%) |
Mar 2023 | - | $8.32 M(-11.7%) |
Dec 2022 | $9.43 M | $9.43 M(-15.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $11.18 M(-15.9%) |
Jun 2022 | - | $13.30 M(-24.8%) |
Mar 2022 | - | $17.67 M(-25.9%) |
Dec 2021 | $23.85 M(+39.1%) | $23.85 M(+193.1%) |
Sep 2021 | - | $8.14 M(-26.3%) |
Jun 2021 | - | $11.03 M(-24.3%) |
Mar 2021 | - | $14.57 M(-15.0%) |
Dec 2020 | $17.14 M(+698.8%) | $17.14 M |
Dec 2019 | $2.15 M | - |
FAQ
- What is Petros Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Petros Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Petros Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of PTPI is $13.34 M
What is the all time high annual cash & cash equivalents for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high annual cash & cash equivalents is $23.85 M
What is Petros Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, PTPI annual cash & cash equivalents has changed by +$3.91 M (+41.49%)
What is Petros Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PTPI is $3.89 M
What is the all time high quarterly cash and cash equivalents for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high quarterly cash and cash equivalents is $23.85 M
What is Petros Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, PTPI quarterly cash and cash equivalents has changed by -$14.08 M (-78.33%)